Pharmacokinetics of tigecycline in critically ill patients with liver failure defined by maximal liver function capacity test (LiMAx)

BACKGROUND: In critically ill patients, tigecycline (TGC) remains an important therapeutic option due to its efficacy against multiresistant Gram-positive and Gram-negative bacteria. TGC is metabolized and eliminated predominantly by the liver. Critical illness-induced liver failure may have a profo...

Descripción completa

Detalles Bibliográficos
Autores principales: Alraish, Rawan, Wicha, Sebastian G., Frey, Otto R., Roehr, Anka C., Pratschke, Johann, Stockmann, Martin, Wuensch, Tilo, Kaffarnik, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403243/
https://www.ncbi.nlm.nih.gov/pubmed/32754775
http://dx.doi.org/10.1186/s13613-020-00707-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403243/
https://www.ncbi.nlm.nih.gov/pubmed/32754775
http://dx.doi.org/10.1186/s13613-020-00707-2

Ejemplares similares